RUNX2 Activation in Fibro/Adipogenic Progenitors Promotes Muscle Fibrosis in Muscular Dystrophy
Advanced Science · 2026-03 · 13 (13)
DOI: 10.1002/advs.202510850 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 22.12.2025. Verfasst von Pengkai Wu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China. Hauptthemen laut MEDLINE: Fibrosis, Muscular Dystrophies, Core Binding Factor Alpha 1 Subunit, Muscle, Skeletal. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Anhui Provincial Natural Science Foundation, Key Project of Natural Science Research of Anhui Provincial Department of Education, National Natural Science Foundation of China.
Abstract (Originalsprache)
Clinical evidence indicates concurrent muscle inflammation and fibrosis in muscular dystrophies (MDs); however, the molecular mechanisms underlying inflammation‐mediated fibrosis in skeletal muscle remain inadequately understood. This study revealed a molecular link between macrophages and fibro‐adipogenic progenitors (FAPs) in both human subjects and mice via the transforming growth factor‐beta (TGF‐β)‐RUNX family transcription factor‐2 (RUNX2) axis. RUNX2 mRNA levels correlated positively with both the expression of fibrotic genes and the fibrosis area of MD patients. We demonstrated that specific ablation of RUNX2 in FAPs alleviated muscle fibrosis in an animal model of MD. Mechanistically, injured myofibers activated the transcription of chemokine genes, enhancing macrophage recruitment and the release of TGF‐β, which subsequently triggered RUNX2‐mediated transcription of fibrogenic genes in FAPs, promoting muscle fibrosis. Additionally, we demonstrated that CADD522, a RUNX2 inhibitor, protects against muscle fibrosis in both dystrophic and denervated mice. Importantly, the anti‐inflammatory drug prednisolone alleviated muscle fibrosis in MD patients by inhibiting inflammatory cytokine‐mediated RUNX2 activation. Collectively, our findings indicated that the TGF‐β‐RUNX2 axis is a viable target for alleviating muscle fibrosis and related diseases, highlighting potential future research directions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
- MOE Innovation Center for Basic Research in Tumor Immunotherapy, Hefei, Anhui, China.
- Anhui Province Key Laboratory of Tumor Immune Microenvironment and Immunotherapy, Hefei, Anhui, China.
- The Affiliated Mental Health Center of Jiangnan University, Wuxi Central Rehabilitation Hospital, Wuxi, Jiangsu, China.
- Division of Spine Surgery, Department of Orthopedic Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China.
- Department of Neurology, Children's Hospital of Fudan University, Shanghai, China.
ORCID-Profile: Pengkai Wu
Förderung
- Anhui Provincial Natural Science Foundation
- Key Project of Natural Science Research of Anhui Provincial Department of Education
- National Natural Science Foundation of China
- The State Key Program of the National Natural Science Foundation of China
- Clinical Research Special Project of Anhui Provincial Department of Science and Technology
- Research Program of Anhui Provincial Department of Education
- Tianshan Talents Project of the Xinjiang Uygur Autonomous Region
- Natural Science Foundation of Anhui Province
Zitieren
APA
Wu, P., Zhang, Z., Zheng, K., Zhu, Z., Zhu, Y., Kiram, A., Zhao, L., Chen, H., Xu, Z., Li, X., Sun, B., Li, Z., & Xu, D. (2026). RUNX2 Activation in Fibro/Adipogenic Progenitors Promotes Muscle Fibrosis in Muscular Dystrophy. Advanced Science, 13(13). https://doi.org/10.1002/advs.202510850
Vancouver
Wu P, Zhang Z, Zheng K, Zhu Z, Zhu Y, Kiram A, et al. RUNX2 Activation in Fibro/Adipogenic Progenitors Promotes Muscle Fibrosis in Muscular Dystrophy. Advanced Science. 2026;13(13). doi:10.1002/advs.202510850
BibTeX
@article{Wu2026,
author = {Wu, Pengkai and Zhang, Zehua and Zheng, Kai and Zhu, Ziqi and Zhu, Yong and Kiram, Abdukahar and Zhao, Lei and Chen, Huihui and Xu, Zhu and Li, Xihua and Sun, Beicheng and Li, Zhijian and Xu, Dengqiu},
title = {RUNX2 Activation in Fibro/Adipogenic Progenitors Promotes Muscle Fibrosis in Muscular Dystrophy},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {13},
doi = {10.1002/advs.202510850}
}
EUVIMED